Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

U.S. Food and Drug Administration

Founders Harvey Washington Wiley Theodore Roosevelt

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 18
Average round size
info
The average size of a deal this fund participated in
$4M
Portfolio companies 18
Rounds per year 0.16
Lead investments 5
Exits 3
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Education
  • Universities
  • Pharmaceutical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of U.S. Food and Drug Administration:
Typical Co-investors
U.S. Food and Drug Administration is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after U.S. Food and Drug Administration:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
CITIC Group Corporation Beijing, Beijing, China
Citius -
Dough Chicago, Illinois, United States
Golden Equator Capital Central Region, Singapore, Singapore
Map Master Aichi Prefecture, Japan, Nagoya
Peilin Nengyuan Touzi China, Fujian, Hunan
Quilvest Luxembourg, Luxembourg
Sandbox Insurtech Ventures Chicago, Illinois, United States
Shumway Capital Connecticut, Greenwich, United States
Watershed Capital Austin, Texas, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Critical Path Institute

Consulting
Medical
14 Sep 2022 Tucson, Arizona, United States

Marker Therapeutics

Biotechnology
Therapeutics
$2M13 Sep 2022 Minneapolis, Minnesota, United States

EpiVax

Analytics
Biotechnology
Pharmaceutical
$2M12 Sep 2022 Providence, Rhode Island, United States

Soligenix

Biopharma
Biotechnology
Health Care
Medical
$2M06 Sep 2022 Princeton, New Jersey, United States

Castle Creek Biosciences

Biopharma
Biotechnology
Life Science
Pharmaceutical
$1M21 Oct 2021 West Whiteland Township, Pennsylvania, United States

Anivive

Biotechnology
Health Care
$500K08 Jul 2021 Long Beach, California, United States

Ability Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$1M22 Oct 2020 Barcelona, Catalonia, Spain

Timber Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$500K06 Apr 2020 New Jersey, United States

Medical Device Innovation Consortium

Biotechnology
Medical Device
$2M21 Oct 2019 Arlington, Virginia, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent U.S. Food and Drug Administration?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: